Global Health & Pharma has unveiled the winners of its prestigious Healthcare and Pharmaceutical Awards 2024, spotlighting the companies revolutionising healthcare’s future. Among this year’s honourees is FundamentalVR, recognised as the Best Surgery Training VR Technology Company. With its trailblazing work in immersive medical and surgical training, FundamentalVR continues to set new standards in transforming how medical professionals are educated worldwide.
A cornerstone of this awards program, now in its ninth year, is its focus on innovation and impact. Organised by Global Health & Pharma Magazine, a trusted voice in the Healthcare, Pharmaceutical, and Life Sciences industries, the awards celebrate organisations that are leading the charge in reshaping their fields. As a publication under AI Global Media, the magazine remains committed to delivering reliable, industry-specific content to an international audience of subscribers, clients, and industry leaders.
Global Health & Pharma Magazine, published quarterly, provides crucial updates and insights into advancements across key sectors. Its mission is to champion those driving change, developing groundbreaking solutions, and pushing the boundaries of healthcare and pharmaceutical excellence. With its broad reach, the publication highlights the cutting-edge technologies and visionary companies shaping the future of medical innovation.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. FundamentalVR is a healthcare technology company with a mission to accelerate human capability via precision simulation.
